Endothelial function and lipid profile of individuals with schizophrenia participating in a supported employment program

Background The social function of individuals with schizophrenia is usually poor and this population exhibits a sedentary lifestyle. Social participation, inclusion in the world of work in particular, might favorably interfere with the lives of these individuals by reducing sedentarism and improving their state of health. Objective To analyze the lipid profile and endothelial function markers among individuals with schizophrenia enrolled in a supported employment program. Methods Quantitative quasi-experimental study conducted with 14 individuals with schizophrenia enrolled in a labor inclusion program. Participants were assessed before enrolment (time-point 1) and one year later (time-point 2). Total cholesterol and fractions, triglycerides, serum nitrates and nitrites (endothelial function markers) were measured. The data were analyzed with software SPSS 20. Results The high-density lipoprotein (HDL) and low-density lipoprotein (LDL) levels exhibited significant changes one year after inclusion in the labor market. HDL increased from 82.30 to 98.60 mg/dL (p<0.01) and LDL decreased from 54.50 to 44.45 mg/dL (p<0.02). The triglyceride and total cholesterol levels remained stable. The nitrate and nitrite level exhibited significant reduction from 15.20 to 14.48 µMol (p<0.01). Conclusion Participation in the supported employment program might have favorably influenced the participants' lipid profile and endothelial function. Nitrites have been described as mediators in the neural inflammatory process, and reduction of their levels is associated with better prognosis of chronic diseases such as schizophrenia.

[1]  C. Chaves,et al.  Influence of sociodemographic and clinical characteristics on the quality of life of patients with schizophrenia. , 2017, Revista da Escola de Enfermagem da U S P.

[2]  T. Raedler,et al.  Microvascular dysfunction in schizophrenia: a case–control study , 2015, npj Schizophrenia.

[3]  L. C. Wagner,et al.  Inclusão ocupacional: perspectiva de pessoas com esquizofrenia , 2015 .

[4]  A. Marques,et al.  Prevalência de perfis lipídico e glicémico alterados em pacientes com esquizofrenia , 2014 .

[5]  D. Fulton,et al.  Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium , 2013, Front. Physiol..

[6]  J. Ornelas,et al.  Os contributos do emprego apoiado para a integração das pessoas com doença mental , 2012 .

[7]  João Paulo Maia-de-Oliveira,et al.  Níveis plasmáticos/séricos do óxido nítrico em pacientes com esquizofrenia: uma revisão sistemática e metanálise , 2012 .

[8]  S. O. D. Paula,et al.  Estresse oxidativo: conceito, implicações e fatores modulatórios , 2010 .

[9]  Dolores María Moreno,et al.  Avaliação antropométrica e bioquímica em pacientes com esquizofrenia usuários de clozapina , 2009 .

[10]  F. J. G. Pitanga Epidemiologia, atividade física e saúde , 2008 .

[11]  Angelina Zanesco,et al.  Óxido nítrico, doenças cardiovasculares e exercício físico , 2006 .

[12]  F. L. Rocha,et al.  Efeitos adversos metabólicos de antipsicóticos e estabilizadores de humor , 2006 .

[13]  André Luiz Colaço,et al.  Citocinas, disfunção endotelial e resistência à insulina , 2006 .

[14]  Michel Milistetd,et al.  Sindrome metabolica: a importancia da atividade física , 2006 .

[15]  Ronald R. Brown,et al.  Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine , 2005, International clinical psychopharmacology.

[16]  Emmanuel Gomes Ciolac,et al.  Exercício físico e síndrome metabólica , 2004 .

[17]  M. Kato,et al.  Prevalence of Metabolic Syndrome in Hispanic and Non-Hispanic Patients With Schizophrenia. , 2004, Primary care companion to the Journal of clinical psychiatry.

[18]  Xueji Zhang,et al.  Measurement of Nitric Oxide Production in Biological Systems by Using Griess Reaction Assay , 2003 .

[19]  Patrícia Picon,et al.  Relação entre estressores, estresse e ansiedade , 2003 .

[20]  Huseyin Vural,et al.  Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia? , 2003, Neuropsychobiology.

[21]  L. Dusse,et al.  Revisão sobre óxido nítrico , 2003 .

[22]  B. Halliwell,et al.  Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.

[23]  Bruno Zilberstein,et al.  Óxido nítrico: o simples mensageiro percorrendo a complexidade. Metabolismo, síntese e funções , 2000 .

[24]  D. Bredt,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Nitric Oxide in Excitable Tissues : Physiological Roles and Disease , 2013 .

[25]  C. Glazebrook,et al.  Incidence of schizophrenia in Nottingham , 1997, British Journal of Psychiatry.

[26]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.